microRNA-145-5p Inhibits Migration, Invasion, and Metastasis in Hepatocellular Carcinoma by Inhibiting ARF6

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–1227. doi:10.1016/j.jhep.2018.01.01229378234
   PubMed Web of Science ®Google Scholar
• Fang JH, Zhou HC, Zhang C, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology. 2015;62(2):452–465. doi:10.1002/hep.2776025711742
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi:10.1016/j.cell.2009.01.00219167326
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522–531. doi:10.1038/nrg137915211354
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med. 2009;60:167–179. doi:10.1146/annurev.med.59.053006.10470719630570
   PubMed Web of Science ®Google Scholar
• Ishii H, Vodnala SK, Achyut BR, et al. miR-130a and miR-145 reprogram Gr-1CD11b myeloid cells and inhibit tumor metastasis through improved host immunity. Nat Commun. 2018;9(1):2611. doi:10.1038/s41467-018-05023-929973593
   PubMed Web of Science ®Google Scholar
• Wong QW, Lung RW, Law PT, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology. 2008;135(1):257–269. doi:10.1053/j.gastro.2008.04.00318555017
   PubMed Web of Science ®Google Scholar
• Gai X, Tang B, Liu F, et al. mTOR/miR-145-regulated exosomal GOLM1 promotes hepatocellular carcinoma through augmented GSK-3β/MMPs. J Genet Genomics. 2019;46(5):235–245. doi:10.1016/j.jgg.2019.03.01331186161
   PubMed Web of Science ®Google Scholar
• D’Souza-Schorey C, Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol. 2006;7(5):347–358. doi:10.1038/nrm191016633337
   PubMed Web of Science ®Google Scholar
• Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem. 2003;278(43):41573–41576. doi:10.1074/jbc.R30002620012912991
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Furukawa S, Hashimoto A, et al. KRASARF6 and AMAP1 are major targets of and mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. Proc Natl Acad Sci USA. 2019;116(35):17450–17459. doi:10.1073/pnas.190176511631399545
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang C, Li W, et al. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1. Mol Ther. 2019;27(2):365–379. doi:10.1016/j.ymthe.2018.09.01830341010
   PubMed Web of Science ®Google Scholar
• Qi S, Su L, Li J, et al. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes. J Exp Clin Cancer Res. 2019;38(1):471. doi:10.1186/s13046-019-1464-931752956
   PubMed Web of Science ®Google Scholar
• Onodera Y, Nam JM, Hashimoto A, et al. Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion. J Cell Biol. 2012;197(7):983–996. doi:10.1083/jcb.20120106522734003
   PubMed Web of Science ®Google Scholar
• Sato H, Hatanaka KC, Hatanaka Y, et al. High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients. Cell Commun Signal. 2014;12(1):17. doi:10.1186/1478-811X-12-1724621372
   PubMed Web of Science ®Google Scholar
• Li M, Wang J, Ng SS, et al. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation. Cancer. 2009;115(21):4959–4972. doi:10.1002/cncr.2455019642173
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Reig M and Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-229307467
   PubMed Web of Science ®Google Scholar
• Lu M, Zhu WW, Wang X, et al. ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal Transition. Cell Metab. 2019;29(4):886–900. doi:10.1016/j.cmet.2018.12.01930661930
   PubMed Web of Science ®Google Scholar
• Lupini L, Pepe F, Ferracin M, et al. Over-expression of the miR-483-3p Overcomes the miR-145/TP53 Pro-apoptotic Loop in Hepatocellular Carcinoma. Oncotarget. 2016;7(21):31361–31371. doi:10.18632/oncotarget.891327120784
   PubMedGoogle Scholar
• Wei F, Ma C, Zhou T, et al. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol cancer. 2017;16(1):132. doi:10.1186/s12943-017-0694-828743280
   PubMed Web of Science ®Google Scholar
• Yu L, Wang S, Lin X, Lu Y, Gu P. MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11. Mol Med Rep. 2018;17(3):3972–3978. doi:10.3892/mmr.2017.834829286137
   PubMed Web of Science ®Google Scholar
• Wang B, Dong W, Li X. miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18. Technol Cancer Res Treat. 2019;18:1533033819850189. doi:10.1177/153303381985018931106707
   PubMed Web of Science ®Google Scholar
• Hernández-Deviez DJ, Casanova JE, Wilson JM. Regulation of dendritic development by the ARF exchange factor ARNO. Nat Neurosci. 2002;5(7):623–624. doi:10.1038/nn86512032543
   PubMed Web of Science ®Google Scholar
• Wu B, Wang Y, Yang XM, et al. Basigin-mediated redistribution of CD98 promotes cell spreading and tumorigenicity in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:110. doi:10.1186/s13046-015-0226-626437640
   PubMed Web of Science ®Google Scholar
• Hsu WC, Li WM, Lee YC, et al. MicroRNA-145 Suppresses Cell Migration and Invasion in Upper Tract Urothelial Carcinoma by Targeting ARF6. FASEB J. 2020;34(4):5975–5992. doi:10.1096/fj.201902555R32077148
   PubMed Web of Science ®Google Scholar
• Dong G, Zhang S, Shen S, et al. SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle. Cell Death Dis. 2020;11(10):837. doi:10.1038/s41419-020-03039-y33037180
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang X, Li W, Chen Y. MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4. J Ovarian Res. 2020;13(1):54. doi:10.1186/s13048-020-00656-132366274
   PubMed Web of Science ®Google Scholar